- Home
- MOLN vs NMG Comparison
MOLN vs NMG Comparison
Compare MOLN & NMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MOLN | NMG |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | Switzerland | Canada |
| Employees | N/A | N/A |
| Industry | | Other Metals and Minerals |
| Sector | | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.8M | 448.1M |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | MOLN | NMG |
|---|---|---|
| Price | $3.98 | $2.48 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $3.75 | ★ $4.22 |
| AVG Volume (30 Days) | 3.4K | ★ 501.7K |
| Earning Date | 10-30-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,000.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.36 | $1.30 |
| 52 Week High | $5.91 | $6.06 |
Technical Indicators
Market Signals| Indicator | MOLN | NMG |
|---|---|---|
| Relative Strength Index (RSI) | 55.40 | 38.90 |
| Support Level | $3.98 | $2.80 |
| Resistance Level | $4.40 | $3.29 |
| Average True Range (ATR) | 0.18 | 0.19 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 68.12 | 8.62 |
Price Performance
Historical ComparisonAbout MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.